Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aural Analytics
Scottsdale, Arizona, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Aural Analytics' Speech Vitals platform is FDA registered as a computerized cognitive assessment aid, with a Breakthrough Device designation in ALS; validated in over 30 clinical studies, and used in pivotal trials for ALS, cognitive impairment, and other neurologic and respiratory conditions
- Therapeutic areas
- PulmonologyNeurologyPsychiatry
- Modalities
- DeviceNon-pharmacological therapyDigital biomarker platformSoftware
- Industry
- Digital Health Medical Devices
02
Partnerships
Linus Health (integration/acquisition)Koneksa Health (digital biomarkers and clinical trials)EverythingALS and Massachusetts General Hospital (clinical research collaborators)
Beyond the preview
Go deeper on Aural Analytics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aural Analytics.